Breast Cancer Clinical Trials

Showing 2321-2340 of 4,817 trials

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

NCT01792882

The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.

Breast CancerColorectal CancerLung Cancer+2 more

Global BioClinicalStarted Feb 2013

Seattle, Washington, United States

UNKNOWNPhase 2

A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.

NCT05670925

The study is being conducted to evaluate the Opportune Administration of Nab-paclitaxel in the First Line Treatment Strategy, Camrelizumab and Famitinib with/without Nab-paclitaxel, of Patients with Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer.

Triple-Negative Breast Cancer

Fudan University46 participantsStarted Mar 2023

Shanghai, Shanghai Municipality, China

UNKNOWNPhase 2

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

NCT05747326

This study was a prospective, single-arm, open-label phase II clinical trial conducted at National cancer center in China.

Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 participantsStarted Jan 2022

Beijing, Beijing Municipality, China

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

Related Searches

Implementation of Online Adaptive Radiotherapy for Breast Cancer Patients on Ethos (BREAST-ART)

Guangzhou Women's Health Cohort Study (GWHCS)

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

Lifestyle, Exercise and Nutrition Study 2 (LEAN 2)

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

Molecular Signature for Breast Cancer

Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer

Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients

Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors